Q&A

Should we welcome the coming wave of anti-obesity drugs, and what’s at stake in the argument over the 14-day limit on embryo research?

Our final Q&A episode of the year tackles two medical ethics questions in the news recently. The first is Wegovy, the ground-breaking anti-obesity drug which has been a controversial sensation in the United States. It is now available (in very limited supply) on the NHS here in the UK, but only for those with quite serious obesity with BMIs of 35 or higher. Should Christians hail this a brilliant medical advance tackling a serious public health issue, or a worrying example of big pharma trying to medicate away our self-control? Next, we discuss a new push by some scientists to soften the ground ahead of a campaign to extend the current 14-day limit on human embryo research. Why do researchers want to keep embryos alive in petri dishes for longer, and will it actually benefit any of us in the end really?

Listen to other episodes of Matters of Life and Death or find us on Spotify, Apple Podcasts, Pocket Casts, Google Podcasts, Podcast Addict, Castbox or whatever app you use to subscribe and receive new episodes sent straight to your device.

Tags
Most read posts
What can we learn from how the early church lived out their faith during their own pandemics?
How are young people different to those who came before, and what can we learn from them?
Navigating the transitions of later life
Living faithfully as we approach retirement, dependence, dementia and death
This Bill is the wrong approach - there is a better way to give individuals and their families dignity at the end of life
Recent posts
Low-tech transhumanism through something as commonplace as cosmetic surgery, is already with us
Our working and personal lives are becoming increasingly infiltrated by simulated persons
Are social media and smartphones ruining children’s mental health?
Spiritual warfare, evil and technology in the 21st century
After the Cass Report, how can Christian parents navigate the fast-changing world and culture of gender medicine?